{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:45:27Z","timestamp":1791463527230,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD065826"],"award-info":[{"award-number":["HD065826"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OD010962"],"award-info":[{"award-number":["OD010962"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OD011107"],"award-info":[{"award-number":["OD011107"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.neuropharm.2016.02.025","type":"journal-article","created":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T22:31:04Z","timestamp":1456093864000},"page":"553-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Peer social interaction is facilitated in juvenile rhesus monkeys treated with fluoxetine"],"prefix":"10.1016","volume":"105","author":[{"given":"Mari S.","family":"Golub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey E.","family":"Hogrefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-8483","authenticated-orcid":false,"given":"Alicia M.","family":"Bulleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuropharm.2016.02.025_bib1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1601-1848.2003.00051.x","article-title":"The utility of the non-human primate model for studying gene by environment interactions in behavioral research","volume":"2","author":"Barr","year":"2003","journal-title":"Genes Brain Behav."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.02.025_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00023210-200519040-00004","article-title":"Social functioning: should it become an endpoint in trials of antidepressants?","volume":"19","author":"Bech","year":"2005","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.neuropharm.2016.02.025_bib3","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/chi.0b013e318154bb57","article-title":"SET-C versus fluoxetine in the treatment of childhood social phobia","volume":"46","author":"Beidel","year":"2007","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.02.025_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","article-title":"Fluoxetine for the treatment of childhood anxiety disorders","volume":"42","author":"Birmaher","year":"2003","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.025_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/NDT.S13171","article-title":"Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors","volume":"6","author":"Briley","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.psychres.2012.09.019","article-title":"Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD","volume":"205","author":"Bussing","year":"2013","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.pbb.2010.09.012","article-title":"Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism","volume":"97","author":"Chadman","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.025_bib8","series-title":"Darwin and Facial Expression","first-page":"11","article-title":"Facial expression of emotion in nonhuman primates","author":"Chevalier-Skolnikoff","year":"1973"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.02.025_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.pra.0000460619.10429.4c","article-title":"Use of antipsychotic medications in pediatric and young adult populations: future research needs","volume":"21","author":"Christian","year":"2015","journal-title":"J.\u00a0Psychiatr. Pract."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-1781(98)00032-8","article-title":"Effects of rearing condition on HPA axis response to fluoxetine and desipramine treatment over repeated social separations in young rhesus monkeys","volume":"79","author":"Clarke","year":"1998","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-3223(99)00027-X","article-title":"Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeys","volume":"46","author":"Clarke","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1034\/j.1399-0004.2003.00115.x","article-title":"Association of autism severity with a monoamine oxidase A functional polymorphism","volume":"64","author":"Cohen","year":"2003","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.02.025_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1399-0004.2010.01471.x","article-title":"Autism severity is associated with child and maternal MAOA genotypes","volume":"79","author":"Cohen","year":"2011","journal-title":"Clin. Genet."},{"issue":"7","key":"10.1016\/j.neuropharm.2016.02.025_bib14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ajmg.b.30738","article-title":"Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene","volume":"147B","author":"Davis","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"4 Suppl.","key":"10.1016\/j.neuropharm.2016.02.025_bib15","first-page":"S17","article-title":"Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning","volume":"11","author":"Dubini","year":"1997","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2016.02.025_bib16","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/cercor\/bhp203","article-title":"Spinogenesis and pruning from early visual onset to adulthood: an intracellular injection study of layer III pyramidal cells in the ventral visual cortical pathway of the macaque monkey","volume":"20","author":"Elston","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2016.02.025_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2009.12.056","article-title":"Spinogenesis and pruning in the primary auditory cortex of the macaque monkey (Macaca fascicularis): an intracellular injection study of layer III pyramidal cells","volume":"1316","author":"Elston","year":"2010","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.02.025_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(00)00211-6","article-title":"Social impulsivity inversely associated with CSF 5-HIAA and fluoxetine exposure in vervet monkeys","volume":"24","author":"Fairbanks","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.02.025_bib19","first-page":"67","article-title":"The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques","volume":"55","author":"Fontenot","year":"2005","journal-title":"Comp. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib20","first-page":"176","article-title":"Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta)","volume":"48","author":"Fontenot","year":"2009","journal-title":"J.\u00a0Am. Assoc. Lab. Anim. Sci."},{"issue":"12","key":"10.1016\/j.neuropharm.2016.02.025_bib21","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/npp.2012.117","article-title":"Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates","volume":"37","author":"Gill","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.025_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2014.04.014","article-title":"The aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake","volume":"56","author":"Godar","year":"2014","journal-title":"J.\u00a0Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12263-013-0381-3","article-title":"Prenatal iron deficiency and monoamine oxidase A (MAOA) polymorphisms: combined risk for later cognitive performance in rhesus monkeys","volume":"9","author":"Golub","year":"2014","journal-title":"Genes Nutr."},{"issue":"20","key":"10.1016\/j.neuropharm.2016.02.025_bib24","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1007\/s00213-014-3537-y","article-title":"Fluoxetine: juvenile pharmacokinetics in a nonhuman primate model","volume":"231","author":"Golub","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1601-183X.2012.00772.x","article-title":"Influence of prenatal iron deficiency and MAOA genotype on response to social challenge in rhesus monkey infants","volume":"11","author":"Golub","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2016.02.025_bib26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1163\/1568539X-00003088","article-title":"Development of sexual and socio-sexual behaviors in free-ranging juvenile male Japanese macaques, Macaca fuscata","volume":"150","author":"Gunst","year":"2013","journal-title":"Behaviour"},{"key":"10.1016\/j.neuropharm.2016.02.025_bib27","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1038\/tp.2014.116","article-title":"Identifying individual differences of fluoxetine response in juvenile rhesus monkeys by metabolite profiling","volume":"4","author":"He","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"4 Suppl.","key":"10.1016\/j.neuropharm.2016.02.025_bib28","first-page":"S25","article-title":"The enhancement of social functioning as a therapeutic principle in the management of depression","volume":"11","author":"Healy","year":"1997","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.02.025_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0269881106065102","article-title":"The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials","volume":"21","author":"Hedges","year":"2007","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"29","key":"10.1016\/j.neuropharm.2016.02.025_bib30","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.1073\/pnas.1001229107","article-title":"Similar patterns of cortical expansion during human development and evolution","volume":"107","author":"Hill","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.02.025_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pnpbp.2014.09.004","article-title":"SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: a study from an Indian population","volume":"56","author":"Jaiswal","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.neuropharm.2016.02.025_bib72","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajp.20281","article-title":"Serotonin function is associated with behavioral response to a novel conspecific in marmosets","volume":"68","author":"Kinnally","year":"2006","journal-title":"Am. J. Primatol"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0031-1291294","article-title":"Therapeutic drug monitoring of children and adolescents treated with fluoxetine","volume":"45","author":"Koelch","year":"2012","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2016.02.025_bib33","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S1734-1140(12)70927-1","article-title":"Drug therapy in autism: a present and future perspective","volume":"64","author":"Kumar","year":"2012","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-010-2147-6","article-title":"Post-drug consequences of chronic atypical antipsychotic drug administration on the ability to adjust behavior based on feedback in young monkeys","volume":"215","author":"Mandell","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2016.02.025_bib35","series-title":"The Development of Expressive Behavior: Biology-environment Interactions","first-page":"117","article-title":"Experiential influences on the development of expressive behaviors in rhesus monkeys","author":"Mason","year":"1985"},{"issue":"39","key":"10.1016\/j.neuropharm.2016.02.025_bib36","doi-asserted-by":"crossref","first-page":"16301","DOI":"10.1073\/pnas.1102187108","article-title":"Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate","volume":"108","author":"Mattison","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/tpj.2013.23","article-title":"Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders","volume":"14","author":"McCracken","year":"2014","journal-title":"Pharmacogen. J."},{"key":"10.1016\/j.neuropharm.2016.02.025_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ntt.2012.07.007","article-title":"Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL\/6J mice","volume":"36","author":"Moy","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.02.025_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1098-2396(19990315)31:4<285::AID-SYN6>3.0.CO;2-5","article-title":"Monoamine oxidase A inhibition by fluoxetine: an in\u00a0vitro and in\u00a0vivo study","volume":"31","author":"Mukherjee","year":"1999","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.02.025_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00963831","article-title":"Brain region differences and some characteristics of monoamine oxidase type A and B activities in the vervet monkey","volume":"4","author":"Murphy","year":"1979","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biopsych.2004.10.012","article-title":"Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys","volume":"57","author":"Newman","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tox.2010.08.002","article-title":"Toxicity assessment of pramipexole in juvenile rhesus monkeys","volume":"276","author":"Patterson","year":"2010","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.02.025_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-3565(25)11218-4","article-title":"Chronic marijuana smoke exposure in the rhesus monkey. II: effects on progressive ratio and conditioned position responding","volume":"260","author":"Paule","year":"1992","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.02.025_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0892-0362(01)00156-8","article-title":"Differential effects of two NMDA receptor antagonists on cognitive-behavioral development in nonhuman primates I","volume":"23","author":"Popke","year":"2001","journal-title":"Neurotoxicol. Teratol."},{"issue":"4747","key":"10.1016\/j.neuropharm.2016.02.025_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.3952506","article-title":"Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex","volume":"232","author":"Rakic","year":"1986","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neuropharm.2016.02.025_bib46","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1037\/a0029761","article-title":"Repeated fluoxetine administration during adolescence stimulates aggressive behavior and alters serotonin and vasopressin neural development in hamsters","volume":"126","author":"Ricci","year":"2012","journal-title":"Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/cap.1990.1.193","article-title":"Behavioral side effects of fluoxetine in children and adolescents","volume":"1","author":"Riddle","year":"1990","journal-title":"J.\u00a0Child. Adolesc. Psychopharm."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ntt.2009.08.011","article-title":"The effects of chronic methylphenidate administration on operant test battery performance in juvenile rhesus monkeys","volume":"32","author":"Rodriguez","year":"2010","journal-title":"Neurotoxicol. Teratol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2016.02.025_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000329417","article-title":"Pharmacokinetics of fluoxetine in rhesus macaques following multiple routes of administration","volume":"88","author":"Sawyer","year":"2011","journal-title":"Pharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2016.02.025_bib50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0145445511408590","article-title":"Do pharmacological and behavioral interventions differentially affect treatment outcome for children with social phobia?","volume":"35","author":"Scharfstein","year":"2011","journal-title":"Behav. Modif."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.2042-7158.2011.01384.x","article-title":"Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model","volume":"64","author":"Sghendo","year":"2012","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2016.02.025_bib52","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00213-013-3329-9","article-title":"Sertraline effects on cerebrospinal fluid monoamines and species-typical socioemotional behavior of female cynomolgus monkeys","volume":"231","author":"Shively","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1176\/appi.ajp.2013.13020183","article-title":"Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior","volume":"171","author":"Shrestha","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.neuropharm.2016.02.025_bib54","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1038\/npp.2012.119","article-title":"Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development","volume":"37","author":"Soto","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1017\/S1092852913000576","article-title":"Are antidepressants effective in quality of life improvement among children and adolescents? A systematic review","volume":"19","author":"Stevanovic","year":"2014","journal-title":"CNS Spectr."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.02.025_bib56","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/aur.196","article-title":"MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders","volume":"4","author":"Tassone","year":"2011","journal-title":"Autism Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00213-002-1049-7","article-title":"Serotonergic intervention affects both social dominance and affiliative behaviour","volume":"161","author":"Tse","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib58","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00213-001-0926-9","article-title":"Difference in serotonergic and noradrenergic regulation of human social behaviours","volume":"159","author":"Tse","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0269881103017002007","article-title":"Reboxetine promotes social bonding in healthy volunteers","volume":"17","author":"Tse","year":"2003","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2016.02.025_bib60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2006-948328","article-title":"Noradrenaline might enhance assertive human social behaviours: an investigation in a flatmate relationship","volume":"39","author":"Tse","year":"2006","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"10.1016\/j.neuropharm.2016.02.025_bib61","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.euroneuro.2014.07.011","article-title":"Using a partner's facial emotion to elucidate social dominance motivation induced by an SSRI","volume":"24","author":"Tse","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.025_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pnpbp.2013.11.010","article-title":"Sexual dimorphic effect in the genetic association of monoamine oxidase A (MAOA) markers with autism spectrum disorder","volume":"50","author":"Verma","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib63","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/hbeh.1997.1420","article-title":"Effects of the selective serotonin reuptake inhibitor fluoxetine on social behaviors in male and female prairie voles (Microtus ochrogaster)","volume":"32","author":"Villalba","year":"1997","journal-title":"Horm. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.02.025_bib64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1754073912451503","article-title":"Facial expressions in nonhuman animals","volume":"5","author":"Waller","year":"2013","journal-title":"Emot. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.025_bib65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10519-005-9017-8","article-title":"Differential functional variability of serotonin transporter and monoamine oxidase a genes in macaque species displaying contrasting levels of aggression-related behavior","volume":"36","author":"Wendland","year":"2006","journal-title":"Behav. Genet."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2016.02.025_bib66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(93)91664-E","article-title":"Intracellular distribution of monoamine oxidase A in selected regions of rat and monkey brain and spinal cord","volume":"612","author":"Westlund","year":"1993","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2016.02.025_bib67","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00004714-200212000-00006","article-title":"Fluoxetine pharmacokinetics in pediatric patients","volume":"22","author":"Wilens","year":"2002","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.025_bib68","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)","volume":"8","author":"Williams","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.02.025_bib69","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neures.2008.11.007","article-title":"Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean","volume":"63","author":"Yoo","year":"2009","journal-title":"Neurosci. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2016.02.025_bib70","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1467-7687.2011.01047.x","article-title":"The association between infants' self-regulatory behavior and MAOA gene polymorphism","volume":"14","author":"Zhang","year":"2011","journal-title":"Dev. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.02.025_bib71","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.infbeh.2014.06.009","article-title":"Identifying the interaction of maternal sensitivity and two serotonin-related gene polymorphisms on infant self-regulation","volume":"37","author":"Zhang","year":"2014","journal-title":"Infant Behav. Dev."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:51:17Z","timestamp":1758437477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816300600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":72,"alternative-id":["S0028390816300600"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.025","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peer social interaction is facilitated in juvenile rhesus monkeys treated with fluoxetine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}